Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0001104659-25-056379·Ridgeback Capital Investments L.P.
Schedule 13G ownership disclosure
ITEOS THERAPEUTICS INC
Common stock, par value $0.001 per share · CUSIP: 46565G104
Event date: 2025-05-28
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Ridgeback Capital Investments L.P.
Shares: 1,442,959.00 · Class: 3.8%
- Ridgeback Capital Investments LLC
Shares: 1,442,959.00 · Class: 3.8%
- Ridgeback Capital Management LLC
Shares: 1,442,959.00 · Class: 3.8%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-25-056379
- Form type
- SCHEDULE 13G
- Filer
- Ridgeback Capital Investments L.P.
- CIK
- CIK 1423994
- Filed
- Jun 04, 2025
- Reporting period
- May 28, 2025
- Description
- Schedule 13G beneficial ownership